-
Founded in:
1999-05-19 -
Country:
China -
Address:
West section of Station Road, Lingbao City -
Tax NO.:
914112827066645112 -
Registered Funds:
6.53 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Calcium lactate |
Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reduces capillary permeability, etc.
More
Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reduces capillary permeability, etc. |
0.25g | 814-80-2 | 10 |
| Starch |
This product is involved in the formation of bones and the reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reducing the permeability of capillaries.
More
This product is involved in the formation of bones and the reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reducing the permeability of capillaries. |
9005-25-8 | 77 | |
| Magnesium stearate |
This product is involved in the formation of bones and the reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reducing the permeability of capillaries.
More
This product is involved in the formation of bones and the reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reducing the permeability of capillaries. |
557-04-0 | 61 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Calcium lactate |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
814-80-2 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cetirizine dihydrochloride |
Selective histamine H1 receptor antagonist, no obvious anticholinergic and anti-5-hydroxytryptamine effect, not easy to pass through the blood-cerebrospinal fluid barrier to act on the central H1 receptor, clinical use of central inhibition is relatively mild
More
Selective histamine H1 receptor antagonist, no obvious anticholinergic and anti-5-hydroxytryptamine effect, not easy to pass through the blood-cerebrospinal fluid barrier to act on the central H1 receptor, clinical use of central inhibition is relatively mild |
83881-52-1 | 54 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Berberine hydrochloride |
It has an inhibitory effect on a variety of Gram-positive and Gram-negative bacteria in vitro, and has a stronger inhibitory effect on hemolytic Streptococcus, Staphylococcus aureus, Vibrio cholerae, Neisseria meningitidis, Shigella, Salmonella typhi, Corynebacterium diphtheriae, etc. It also has a certain inhibitory effect on amoeba.
More
It has an inhibitory effect on a variety of Gram-positive and Gram-negative bacteria in vitro, and has a stronger inhibitory effect on hemolytic Streptococcus, Staphylococcus aureus, Vibrio cholerae, Neisseria meningitidis, Shigella, Salmonella typhi, Corynebacterium diphtheriae, etc. It also has a certain inhibitory effect on amoeba. |
100mg | 633-65-8 | 46 |
| Trimethoprim |
It mainly interferes with bacterial folate metabolism, selectively inhibits dihydrofolate reductase, and prevents nucleic acid synthesis.
More
It mainly interferes with bacterial folate metabolism, selectively inhibits dihydrofolate reductase, and prevents nucleic acid synthesis. |
50mg | 738-70-5 | 44 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nalmefene hydrochloride |
Nalmefene is an opioid receptor antagonist that can inhibit or reverse the respiratory depression, sedation, and hypotension effects of opioid drugs. Pharmacodynamic studies have shown that the duration of action of nalmefene is longer than that of naloxone at a complete reversal dose. Nalmefene has no opioid agonist activity and does not produce respiratory depression, hallucinogenic effects, or mydriasis. No pharmacological effects were observed when nalmefene was administered in the absence of an opioid agonist. No tolerance, physical dependence, or abuse liability of nalmefene was observed in the study. In opioid-dependent individuals, nalmefene can produce acute withdrawal symptoms.
More
Nalmefene is an opioid receptor antagonist that can inhibit or reverse the respiratory depression, sedation, and hypotension effects of opioid drugs. Pharmacodynamic studies have shown that the duration of action of nalmefene is longer than that of naloxone at a complete reversal dose. Nalmefene has no opioid agonist activity and does not produce respiratory depression, hallucinogenic effects, or mydriasis. No pharmacological effects were observed when nalmefene was administered in the absence of an opioid agonist. No tolerance, physical dependence, or abuse liability of nalmefene was observed in the study. In opioid-dependent individuals, nalmefene can produce acute withdrawal symptoms. |
58895-64-0 | 19 |